Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RLAY
RLAY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RLAY News
Relay Therapeutics Achieves Breakthrough in Drug Trials
May 22 2026
Fool
Relay Therapeutics Shows Strong Performance Post-IPO
May 22 2026
NASDAQ.COM
Relay Therapeutics Achieves Breakthrough in Clinical Trials
May 22 2026
Yahoo Finance
Relay Therapeutics Prices Public Offering at $12.00 per Share
May 21 2026
seekingalpha
Relay Therapeutics Prices Public Offering at $12 per Share
May 21 2026
NASDAQ.COM
Relay Therapeutics Prices Public Offering at $12 per Share
May 21 2026
Newsfilter
Relay Therapeutics Shares Surge 8% Following Positive Analyst Ratings and Drug Results
May 21 2026
Fool
Relay Therapeutics Shares Surge on Bullish Analyst Upgrades
May 21 2026
NASDAQ.COM
Barclays Raises Relay Therapeutics Price Target to $27, Signaling 124% Upside
May 20 2026
stocktwits
Relay Therapeutics Proposes $175 Million Public Offering
May 20 2026
NASDAQ.COM
Relay Therapeutics Announces $175M Underwritten Public Offering
May 19 2026
seekingalpha
US Stocks Retreat as Tech Rally Falters
May 19 2026
NASDAQ.COM
U.S. Stocks Decline as Tech Rally Falters
May 19 2026
NASDAQ.COM
Relay Therapeutics Reports Strong Early-Stage Data for Zovegalisib
May 19 2026
stocktwits
Relay Therapeutics Reports Initial Clinical Results of Zovegalisib in Phase 2 Trial
May 19 2026
NASDAQ.COM
Relay Therapeutics' Zovegalisib Shows Promising Mid-Stage Trial Results
May 19 2026
seekingalpha
Show More News
